Network Bio develops AI platforms designed to learn from human biology and support medical research and healthcare applications.
Network Bio has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2026.
Network Bio's investors include Founders Fund, Fundomo, S32, Thiel Capital, Artis Ventures.
Network Bio is headquartered in New York, United States.
Network Bio develops AI platforms designed to learn from human biology and support medical research and healthcare applications.
Network Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Network Bio — Funding & Investors." VCBacked, August 19, 2026, https://www.vcbacked.co/company/network-bio. Accessed November 13, 2026.
VCBacked. (2026). Network Bio — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/network-bio
{{cite web |title=Network Bio — Funding & Investors |url=https://www.vcbacked.co/company/network-bio |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Network Bio? Request a listing update